Pleomorphic adenoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
 
(5 intermediate revisions by the same user not shown)
Line 2: Line 2:
{{Pleomorphic adenoma}}
{{Pleomorphic adenoma}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{M.N}}
==Overview==
==Overview==
The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population. It accounts for 45-75% of all salivary gland neoplasms. Females are more commonly affected than males.
The annual [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 [[population]]. It accounts for 45-75% of all [[salivary gland]] [[neoplasms]]. [[Females]] are more commonly affected than [[males]].


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The annual incidence of pleomorphic adenoma  is approximately 2-3.5 cases per 100,000 population.<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref>
*The annual [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma  is approximately 2-3.5 cases per 100,000 [[population]].<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref>
*It accounts for 45-75% of all [[salivary gland neoplasms]].
*It accounts for 45-75% of all [[salivary gland neoplasms]].
*Pleomorphic adenoma distribution among the salivary glands is as follows<ref name="pmid27040584">{{cite journal |vauthors=Zhan KY, Khaja SF, Flack AB, Day TA |title=Benign Parotid Tumors |journal=Otolaryngol. Clin. North Am. |volume=49 |issue=2 |pages=327–42 |date=April 2016 |pmid=27040584 |doi=10.1016/j.otc.2015.10.005 |url=}}</ref>:
*Pleomorphic adenoma distribution among the [[salivary glands]] is as follows<ref name="pmid27040584">{{cite journal |vauthors=Zhan KY, Khaja SF, Flack AB, Day TA |title=Benign Parotid Tumors |journal=Otolaryngol. Clin. North Am. |volume=49 |issue=2 |pages=327–42 |date=April 2016 |pmid=27040584 |doi=10.1016/j.otc.2015.10.005 |url=}}</ref>:
**[[Parotid gland]]: 84%
**[[Parotid gland]]: 84%
**[[Submandibular gland]]: 8%
**[[Submandibular gland]]: 8%
**Minor salivary glands: 6.5%
**Minor [[salivary glands]]: 6.5%


===Age===
===Age===
*People of all age groups may develop pleomorphic adenoma.<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref>
*People of all [[age]] groups may develop pleomorphic adenoma.<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref>
*The incidence of pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.
*The [[Incidence (epidemiology)|incidence]] of pleomorphic adenoma increases with [[age]]; the average [[age]] at [[diagnosis]] is 43-46 years.


===Race===
===Race===
*There is no racial predilection to pleomorphic adenoma.
*There is no [[racial]] predilection to pleomorphic adenoma.


===Gender===
===Gender===
*Females are predominantly affected by Pleomorphic adenoma than males. The female to male ratio is approximately (2:1)
*[[Females]] are predominantly affected by pleomorphic adenoma than [[males]]. The [[female]] to [[male]] ratio is approximately (2:1)<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref>


==References==
==References==
Line 30: Line 30:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
 
[[Category: Otolaryngology]]
[[Category: Medicine]]
[[Category: Oncology]]
[[Category: Surgery]]
[[Category: Up-To-Date]]

Latest revision as of 19:29, 28 January 2019

Pleomorphic adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pleomorphic adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pleomorphic adenoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pleomorphic adenoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pleomorphic adenoma epidemiology and demographics

CDC on Pleomorphic adenoma epidemiology and demographics

Pleomorphic adenoma epidemiology and demographics in the news

Blogs on Pleomorphic adenoma epidemiology and demographics

Directions to Hospitals Treating Pleomorphic adenoma

Risk calculators and risk factors for Pleomorphic adenoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]

Overview

The annual incidence of pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population. It accounts for 45-75% of all salivary gland neoplasms. Females are more commonly affected than males.

Epidemiology and Demographics

Incidence

Age

  • People of all age groups may develop pleomorphic adenoma.[1]
  • The incidence of pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.

Race

  • There is no racial predilection to pleomorphic adenoma.

Gender

References

  1. 1.0 1.1 1.2 Pinkston JA, Cole P (June 1999). "Incidence rates of salivary gland tumors: results from a population-based study". Otolaryngol Head Neck Surg. 120 (6): 834–40. doi:10.1016/S0194-5998(99)70323-2.
  2. Zhan KY, Khaja SF, Flack AB, Day TA (April 2016). "Benign Parotid Tumors". Otolaryngol. Clin. North Am. 49 (2): 327–42. doi:10.1016/j.otc.2015.10.005. PMID 27040584.

Template:WH Template:WS